Robert Lenz

Robert Lenz

Director/Board Member at NOVABRIDGE BIOSCIENCES

Net worth: 571 820 $ as of 2026-05-30

55 year
Health Technology
Consumer Services
Producer Manufacturing

Profile

Robert A. Lenz is currently Co-Managing Director at Lenz, Kämper GmbH & Co. KG.
He is also an Independent Director at LB Pharmaceuticals, Inc. starting in 2026 and an Independent Director at NovaBridge Biosciences starting in 2025.
Formerly, Dr. Lenz was Senior Vice President & Head-Global Development at Amgen, Inc. and Head-Research & Development at Neumora Therapeutics, Inc. Dr. Lenz earned a doctorate from the University of Maryland and completed undergraduate studies at Dickinson College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2025-02-17 309,092 ( 0.17% ) 571 820 $ 2026-05-30

Robert Lenz active positions

CompaniesPositionStart
NOVABRIDGE BIOSCIENCES Director/Board Member 2025-08-21
LB PHARMACEUTICALS INC Director/Board Member 2026-03-05
Chief Executive Officer -

Former positions of Robert Lenz

CompaniesPositionEnd
NEUMORA THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer -
AMGEN INC. Corporate Officer/Principal -
See the detail of Robert Lenz's experience

Training of Robert Lenz

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

5

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Producer Manufacturing

Health Technology

Health Technology

Health Technology